Firm working on vaccine to treat HFMD


GEORGE TOWN: A Malaysia-based biotech company is set to develop a vaccine in eight years for the EV71 virus, which causes the infectious and potentially fatal hand, foot and mouth disease (HFMD).

The company embarking on this ambitious task is Sentinext Therapeutics Sdn Bhd with its laboratory in Universiti Sains Malaysia (USM), Penang.

Its chief scientific officer Prof Dr Jane Cardosa said there was currently no vaccine or anti-viral agent to prevent or treat EV71 infection.

She added that the lab had found a vaccine candidate and was going through pre-clinical tests.

“Hopefully after 18 months, we can move to Phase 1 where we will test its safety on humans followed by efficacy trials (Phase 2). If the vaccine is taken up when it is (fully) developed, children can be protected from EV71, HFMD and some other diseases,” she said at a media briefing in USM yesterday.

“However, we won’t see the end of HFMD as it can still be caused by other viruses.”

The 59-year-old professor retired as Universiti Sarawak Malaysia Institute of Health and Community Medicine director in late August and is now a visiting professor at USM.

The vaccine being developed by Sentinext Therapeutics is a significant breakthrough because the EV71 virus has been consistently causing outbreaks of HFMD in many countries in the Asia-Pacific region.

Prof Cardosa said the Singapore government had funded a company to research and develop a vaccine for the virus but it ceased operations after running out of funds.

The China government has also invested in a similar project but has a different approach from what Prof Cardosa’s lab is doing.

“Our vaccine is formulated from empty capsids to mimic the virus particle but there is no genome. So, it is not infectious,” she said.

Sentinext Therapeutics received a RM40mil fund from the Malaysian Life Sciences Capital Fund and Malaysian Technology Development Corp.

Besides developing and researching a vaccine for EV71, the company is also looking at vaccines for other tropical infectious diseases like malaria and dengue.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Nation

Steven Sim brushes off PAS' prediction of Pakatan govt collapsing
Leaw vows to serve Temiang harder
Another student killed in crash while returning from RXZ gathering
Negri Sembilan's special holiday on Monday not compulsory for private sector, says Labour Dept
No arrests of Rohingya refugees outside UNHCR office, says KL cop
DPM congratulates Aaron-Tai, Pearly-Thinaah for Taiwan Open performance
Biker killed, two injured after crash with MPV near Kulai
Kelantan cops: Share intel if Thai shooting suspects fled to Malaysia
No need to rush GE16, govt should complete term, says MP
Death and grief keep following motorcycle events, says Dzulkefly

Others Also Read